- Home
- RF vs WAT Comparison
RF vs WAT Comparison
Compare RF & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RF
- WAT
- Stock Information
- Founded
- RF 1970
- WAT 1958
- Country
- RF United States
- WAT United States
- Employees
- RF N/A
- WAT N/A
- Industry
- RF Major Banks
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- RF Finance
- WAT Industrials
- Exchange
- RF Nasdaq
- WAT Nasdaq
- Market Cap
- RF 24.1B
- WAT 17.4B
- IPO Year
- RF N/A
- WAT 1995
- Fundamental
- Price
- RF $23.53
- WAT $335.91
- Analyst Decision
- RF Buy
- WAT Buy
- Analyst Count
- RF 18
- WAT 15
- Target Price
- RF $27.22
- WAT $373.13
- AVG Volume (30 Days)
- RF 26.2M
- WAT 695.4K
- Earning Date
- RF 10-17-2025
- WAT 11-04-2025
- Dividend Yield
- RF 4.50%
- WAT N/A
- EPS Growth
- RF 27.33
- WAT 10.77
- EPS
- RF 2.26
- WAT 11.09
- Revenue
- RF $6,945,000,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- RF $17.80
- WAT $7.15
- Revenue Next Year
- RF $4.41
- WAT $6.34
- P/E Ratio
- RF $10.44
- WAT $30.18
- Revenue Growth
- RF 5.90
- WAT 5.89
- 52 Week Low
- RF $17.74
- WAT $275.05
- 52 Week High
- RF $27.96
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- RF 29.51
- WAT 65.39
- Support Level
- RF $24.27
- WAT $323.46
- Resistance Level
- RF $25.31
- WAT $338.37
- Average True Range (ATR)
- RF 0.77
- WAT 10.10
- MACD
- RF -0.27
- WAT 1.52
- Stochastic Oscillator
- RF 19.90
- WAT 95.15
About RF Regions Financial Corporation
Regions Financial is a regional bank based in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, and trust services.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.